Biomonitoring of nurses occupationally exposed to antineoplastic drugs: the IMEPA Project

To develop a multiple-endpoint monitoring system in order to assess and minimize long term risks in hospital nurses exposed to antiblastic drugs. Molecular epidemiology study. S. Orsola-Malpighi Hospital in Bologna, Italy: nurses exposed to antiblastic drugs. 50 exposed subjects (8 males and 42 fema...

Full description

Saved in:
Bibliographic Details
Published inEpidemiologia e prevenzione Vol. 29; no. 5-6 Suppl; p. 91
Main Authors Bolognesi, Claudia, Nucci, Maria Concetta, Colacci, Anna Maria, Grilli, Sandro, Ippoliti, Flora, Mucci, Nicolina, Romano Spica, Vincenzo, Barbieri, Anna, Canitano, Nicoletta, Chiozzotto, Daniela, Di Renzo, Livia, Giordano, Elena, Horn, Wolfango, Roggieri, Paola, Risi, Alessandro, Silingardi, Paola, Vaccari, Monica, Violante, Francesco Saverio
Format Journal Article
LanguageItalian
Published Italy 01.09.2005
Subjects
Adult
Antineoplastic Agents - urine
Environmental Monitoring
Female
Humans
Male
Nurses
Occupational Exposure - analysis
Online AccessGet more information

Cover

More Information
Summary:To develop a multiple-endpoint monitoring system in order to assess and minimize long term risks in hospital nurses exposed to antiblastic drugs. Molecular epidemiology study. S. Orsola-Malpighi Hospital in Bologna, Italy: nurses exposed to antiblastic drugs. 50 exposed subjects (8 males and 42 females) and 50 unexposed individuals (8 males and 42 females) matched for age and smoking habits. Urinary markers of exposure, Heat Shock Proteins (HSPs) 27, 70, 90, 110, immunologic biomarkers in peripheral blood lymphocytes: apoptosis, cell-cycle analysis G1-S-G, typization of Natural Killer cells (NK) and receptors micronuclei; frequency in peripheral blood lymphocytes and in exfoliated buccal mucosa cells; activation ofspecific oncogenes (bax, bcl2). 19/50 subjects showed urinary antiblastic drug levels (3 subjects MTX, 11 subjects CP, 5 subjects MTX and CP). No statistically significant differences were observed in all the considered biomarkers between the exposed and control groups. This biomonitoring study doesn't evidence any early significant effect associated to the exposure to antiblastic drugs.
ISSN:1120-9763